Detalhe da pesquisa
1.
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.
Proc Natl Acad Sci U S A
; 120(1): e2209944120, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574650
2.
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Proc Natl Acad Sci U S A
; 118(1)2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33376202
3.
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity.
Brain
; 145(5): 1711-1725, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35661859
4.
Classification of neurological diseases using multi-dimensional CSF analysis.
Brain
; 144(9): 2625-2634, 2021 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33848319
5.
Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.
Brain
; 144(10): 3126-3141, 2021 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849598
6.
Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release.
Proc Natl Acad Sci U S A
; 116(1): 271-276, 2019 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559188
7.
High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients.
Mult Scler
; 27(10): 1491-1496, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150829
8.
Sex bias in MHC I-associated shaping of the adaptive immune system.
Proc Natl Acad Sci U S A
; 115(9): 2168-2173, 2018 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29440397
9.
VLA-2 blockade in vivo by vatelizumab induces CD4+FoxP3+ regulatory T cells.
Int Immunol
; 31(6): 407-412, 2019 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30783682
10.
Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis.
Brain
; 142(11): 3411-3427, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563951
11.
Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data.
BMC Neurol
; 19(1): 190, 2019 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399069
12.
Targeting MCAM for next-generation modulation of leucocyte trafficking.
Brain
; 146(4): 1236-1237, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36946303
13.
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Proc Natl Acad Sci U S A
; 113(21): E2973-82, 2016 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27162345
14.
Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus.
J Neuroinflammation
; 15(1): 236, 2018 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30134924
15.
Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters.
Mult Scler
; 24(5): 563-573, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28847222
16.
Dual action by fumaric acid esters synergistically reduces adhesion to human endothelium.
Mult Scler
; 24(14): 1871-1882, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28984166
17.
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.
Int Immunol
; 27(1): 47-53, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25326459
18.
PML risk stratification using anti-JCV antibody index and L-selectin.
Mult Scler
; 22(8): 1048-60, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26432858
19.
Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity.
Ann Neurol
; 75(5): 739-58, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24771567
20.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
BMC Neurol
; 15: 96, 2015 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26099927